文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

体外膜氧合支持下高压氧治疗气体栓塞的技术可行性:简要报告

Technical feasibility of hyperbaric oxygen therapy for gas embolism with ECMO support: a brief report.
PubMed 文献 · Crit Care · 2026-03-12
一句话结论使用Rotaflow I®装置并将控制台置于高压舱外,对ECMO支持的气体栓塞患者实施高压氧治疗似乎技术可行,未见性能显著影响或持续性溶血效应。

该简要报告旨在评估在高压氧治疗(HBOT)期间使用Rotaflow I®(Maquet,德国)ECMO装置的可行性,装置配置为模拟循环环路(MCL),泵头单元和氧合器位于高压舱内、控制台位于舱外。对照组MCL置于高压舱外,具有相似特性和参数,两个氧合器均通入氧气吹扫气。在加压方案前、中、后测量流出量稳定性,并评估溶血实验室标志物,同时测量两个MCL。结果显示ECMO流出量在高压加压方案期间保持稳定,最大变异为HBOT期间0.16 L/min(3.1%)vs 大气压下0.19 L/min(3.8%)。H-ECMO装置氧合器前后压力无显著变异(氧合器前后最大差值1 mmHg)。血红蛋白、结合珠蛋白和裂红细胞浓度保持稳定;相反,暴露于HBOT的装置中测得的血浆游离血红蛋白和LDH在运行期间暂时升高,回到大气压后下降,这些变化可能与技术问题有关,对照组未见相关变化。结论认为,使用Rotaflow I®装置并将控制台外置于高压舱外,对ECMO支持的气体栓塞患者实施HBOT似乎技术可行,未观察到对性能的显著影响或对溶血的持续效应。

要点

  • 在模拟循环环路中,ECMO流出量在高压氧治疗期间保持稳定,最大变异为0.16 L/min(3.1%),大气压下为0.19 L/min(3.8%)。
  • H-ECMO装置氧合器前后压力无显著变异,最大差值为1 mmHg。
  • 血红蛋白、结合珠蛋白和裂红细胞浓度保持稳定,未见持续性溶血效应。
  • 暴露于HBOT的装置中血浆游离血红蛋白和LDH暂时升高,回到大气压后下降,可能与技术问题有关。
  • 使用Rotaflow I®装置并将控制台置于高压舱外,对ECMO支持的气体栓塞患者实施HBOT似乎技术可行。

适用人群与场景

  • 体外膜氧合(ECMO)支持的气体栓塞(GE)患者,适用于评估高压氧治疗(HBOT)的技术可行性场景。

处置流程与药物剂量

  • 使用Rotaflow I®(Maquet,德国)ECMO装置,配置为模拟循环环路(MCL),泵头单元和氧合器位于高压舱内,控制台位于舱外。
  • 两个氧合器均通入氧气吹扫气。
  • 在加压方案前、中、后测量流出量稳定性,并评估溶血实验室标志物。

研究设计与关键结果

  • 研究类型为简要报告,采用模拟循环环路(MCL)评估技术可行性,未报告样本量或中心数。
  • ECMO流出量在高压加压方案期间保持稳定,最大变异为HBOT期间0.16 L/min(3.1%)vs 大气压下0.19 L/min(3.8%)。
  • H-ECMO装置氧合器前后压力无显著变异,最大差值为1 mmHg。
  • 血红蛋白、结合珠蛋白和裂红细胞浓度保持稳定。
  • 暴露于HBOT的装置中血浆游离血红蛋白和LDH暂时升高,回到大气压后下降;对照组未见相关变化。

证据类型、等级与局限

  • 证据类型为简要报告(体外模拟循环环路研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,使用Rotaflow I®装置并将控制台外置于高压舱外,对ECMO支持的气体栓塞患者实施HBOT似乎技术可行,未观察到对性能的显著影响或对溶血的持续效应。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Gas embolism (GE) occurs when gas enters into the circulation. Whilst small quantities of gas may be harmless, massive, or systemic GE may be life-threatening, when associated with coma, cardiogenic shock, or cardiac arrest. GE is a known complication of Extracorporeal Membrane Oxygenation (ECMO). Hyperbaric Oxygen Therapy (HBOT) is a corner-stone of GE management. Delivery of HBOT in patients supported by ECMO is an emerging area of interest. METHODS: We aimed to assess the feasibility of using the Rotaflow I® (Maquet, Germany) ECMO device during HBOT, configured with mock circulatory loops (MCL) such that the pump head unit and oxygenator were located inside and the console external to the hyperbaric chamber. A control MCL was positioned outside the hyperbaric chamber with similar characteristics and parameters. Both oxygenators were alimented with oxygen sweep gas. Outflow stability was measured before, during and after a pressurization profile. Laboratory markers for hemolysis were assessed. Measurements were performed simultaneously on both MCL. RESULTS: ECMO outflow displayed on the console remained stable during hyperbaric pressurization profile. [maximum variation (delta max) of 0.16 L/min (3.1%) during HBOT versus 0.19 L/min (3.8%) at atmospheric pressure]. No significant variation was found between pre- and post-oxygenator pressure in the H-ECMO device (delta max 1 mmHg in pre- and post-oxygenator). Hemoglobin, haptoglobin and schistocytes concentrations remained stable. Conversely, measured plasma-free hemoglobin and LDH were increased temporarily during run in the device exposed to HBOT, then decreased when back at atmospheric pressure. These changes are likely related to technical issues. No relevant changes were observed in the control. CONCLUSION: Delivery of HBOT to patients with GE supported by ECMO seems technically feasible using a Rotaflow I® device with externalization of the console outside the hyperbaric chamber. No significant effect on performance or sustained effect on hemolysis were observed.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Delforge Q, Legrand G, Duburcq T, et al. Technical feasibility of hyperbaric oxygen therapy for gas embolism with ECMO support: a brief report. Crit Care. 2026. PMID: 41821110. doi:10.1186/s13054-026-05949-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。